Skip to main content

CITADEL ADVISORS LLC

Position in LTRN — Lantern Pharma Inc.

CIK 1423053 MIAMI, FL

Position in LTRN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$199,721
+$100,050 QoQ
Shares Held
47,895
+45.6% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 39 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LTRN Over Time

Shares Held

Position Value (USD)

Derivatives in LTRN

reported options exposure · as of Dec 31, 2025
CallValue
$37,269
CallShares
12,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. LTRN ranks #319 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LTRN

Export CSV
37 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $199,721 47,895
2025-12-31 $99,671 32,895
2025-12-31 $37,269 12,300
2025-09-30 $80,040 18,400
2025-06-30 $51,824 16,400
2025-03-31 $60,534 17,100
2025-03-31 $4,602 1,300
2024-12-31 $119,902 37,587
2024-12-31 $14,674 4,600
2024-12-31 $1,914 600
2024-09-30 $146,066 39,800
2024-09-30 $22,387 6,100
2024-09-30 $7,901 2,153
2024-06-30 $199,876 42,800
2024-06-30 $26,152 5,600
2024-03-31 $175,120 19,900
2024-03-31 $73,920 8,400
2023-12-31 $106,392 24,858
2023-12-31 $856 200
2023-12-31 $1,712 400
2023-09-30 $104,454 30,632
2023-09-30 $23,188 6,800
2023-09-30 $7,502 2,200
2023-06-30 $139,515 24,737
2023-06-30 $1,128 200
2023-06-30 $1,128 200
2023-03-31 $53,013 10,976
2023-03-31 $1,932 400
2023-03-31 $36,225 7,500
2022-12-31 $116,698 19,321
2022-12-31 $2,416 400
2022-12-31 $41,072 6,800
2022-09-30 $54,014 11,300
2022-09-30 $60,959 12,753
2022-09-30 $69,310 14,500
2021-12-31 $88,538 11,095
2021-03-31 $203,022 11,192